Your browser doesn't support javascript.
loading
Functional role of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in NSCLC.
Cao, Yueyu; Wei, Mengdan; Li, Bing; Liu, Yali; Lu, Ying; Tang, Zhipeng; Lu, Tianbao; Yin, Yujiao; Qin, Zhiqiang; Xu, Zengguang.
Afiliación
  • Cao Y; Department of Oncology, Shanghai East Hospital, Dalian Medical University, Shanghai 200120, China.
  • Wei M; Research Center for Translational Medicine and Key Laboratory of Arrhythmias, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
  • Li B; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
  • Liu Y; Research Center for Translational Medicine and Key Laboratory of Arrhythmias, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
  • Lu Y; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
  • Tang Z; Research Center for Translational Medicine and Key Laboratory of Arrhythmias, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
  • Lu T; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
  • Yin Y; Research Center for Translational Medicine and Key Laboratory of Arrhythmias, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
  • Qin Z; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
  • Xu Z; Research Center for Translational Medicine and Key Laboratory of Arrhythmias, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Oncotarget ; 7(17): 24242-51, 2016 Apr 26.
Article en En | MEDLINE | ID: mdl-27003362
ABSTRACT
Eukaryotic translation initiation factor 4 gamma 1(EIF4G1) is related to tumorigenesis and tumor progression. However, its role and the underlying mechanisms in the regulation of tumor development in non-small cell lung cancers (NSCLC) remain largely unknown. Here we report that the levels of EIF4G1 expression are much higher in NSCLC cell lines and tumor tissues than those in the normal lung cells and adjacent normal tissues from the same patients. Using shRNA to knock down EIF4G1 expression stably, we found EIF4G1 required for NSCLC cell proliferation, anchorage-independent growth, migration and invasion. Furthermore, silencing of EIF4G1 induces NSCLC cell apoptosis and causes G0/G1 cell cycle arrest. To identify the partner protein network of EIF4G1 in NSCLC cells, we found that Ubiquitin-specific protease 10 (USP10) can directly interacts with EIF4G1, while acting as a negative regulator for EIF4G1-mediated functions. Together, our results indicate that EIF4G1 functions as an oncoprotein during NSCLC development, which may represent a novel and promising therapeutic target in lung cancer.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Transformación Celular Neoplásica / Carcinoma de Pulmón de Células no Pequeñas / Factor 4G Eucariótico de Iniciación / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Transformación Celular Neoplásica / Carcinoma de Pulmón de Células no Pequeñas / Factor 4G Eucariótico de Iniciación / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: China